March 3, 2025
FOR IMMEDIATE RELEASE
Modus Health appoints Dr. Amir Lahav, a renowned leader in AI-driven digital health solutions, to its Advisory Board to enhance clinical trials and healthcare business.
Seattle, WA – March 3, 2025 – Modus Health, a leader in activity monitoring solutions, is pleased to announce the appointment of Dr. Amir Lahav to its Advisory Board. Dr. Lahav brings over two decades of experience in healthcare innovation, specializing in integrating cutting-edge technologies for remote patient monitoring and improved health outcomes. Dr. Lahav is the Founder and CEO of SkyMedAI, a forward-thinking consulting boutique dedicated to transforming the diagnosis, monitoring, and treatment of human diseases through “Human-AI Fusion.” His expertise lies in developing and commercializing pioneering solutions in drug development and precision medicine.
At Modus Health, Dr. Lahav will focus on expanding the company’s presence in clinical trials and healthcare sectors, leveraging his extensive background and expertise to drive innovation and strategic growth.
“I am excited and honored to join the Modus Health team and look forward to elevating the company to new heights!” says Dr. Lahav. “I can’t think of a better device on the market that reliably maintains such high levels of step detection accuracy in real-world settings, especially in individuals with mobility disabilities. This exceptional precision is crucial to accurately determining drug efficacy and health outcomes”.
“We are thrilled to welcome Amir to our team,” says Teri Rosenbaum-Chou, PhD, President & CEO of Modus Health. “Amir’s vast experience, extensive network, and profound knowledge of the pharma and healthcare sectors align perfectly with our mission to revolutionize clinical trials by providing unmatched accuracy in activity monitoring and mobility measures. I am excited about the extraordinary advancements we can achieve together.”
Modus Health is renowned for its flagship product, StepWatch™, an FDA-listed and CE-marked medical device recognized as the gold standard for activity monitoring of real-world mobility. Validated in over 600 peer-reviewed publications, StepWatch™ is trusted by leading research institutions and companies worldwide for its unparalleled accuracy in measuring walking activity, especially in disabled individuals with slow or irregular gait.
Adding Dr. Lahav to the Advisory Board underscores Modus Health’s commitment to advancing its clinical trial offerings and healthcare solutions, reinforcing its position as a leader in precise, evidence-based activity monitoring.
About Modus Health
Modus Health is a medical device and software company focused on improving healthcare outcomes through precise, evidence-based decision-making. Combining highly accurate activity monitors with proprietary software, Modus Health provides objective data for clinical decisions and treatment evaluations. For over 10 years, the company has maintained a tradition of excellence in data collection and analysis, serving a wide range of applications from clinical trials to ongoing clinical care.
Media Contact
Modus Health LLC
Email: [email protected]
Phone: +1 (202) 830-1100
Website: https://modushealth.com/
